• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-9、2及其抑制剂-金属蛋白酶组织抑制因子-1、2在侵袭性垂体腺瘤生物学行为中的作用

[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].

作者信息

He Dong-sheng, Chen Ming-zhen, Wang Hai-jun, Ke Chun-long, Yan Chao, Zheng Heng, Hong Yi-shan

机构信息

Department of Neurosurgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.

出版信息

Ai Zheng. 2002 Oct;21(10):1124-8.

PMID:12508658
Abstract

BACKGROUND & OBJECTIVE: Usually pituitary adenomas are histological benign and grow slowly, but a proportion of them will become locally aggressive, and develop into invasive pituitary adenomas. The reasons for these differences in tumor behavior are poorly understood. Pituitary adenomas are abounding blood vessels. Angiogenesis and tumor invasion both require degradation of the extracellular matrix components to allow cell migration. The matrix metalloproteinases (MMPs) and their nature inhibitors-the tissue inhibitors of metalloproteinases (TIMPs) may play a central role in these processes. The aggressive mechanism of pituitary adenomas was studied through investigating the expression of MMP-9, MMP-2, TIMP-1, and TIMP-2 in both invasive and non-invasive adenomas.

METHODS

Sixty-one surgical removed pituitary adenomas (forty-nine cases invasive and twelve non-invasive adenomas) were investigated. Immunohistochemistry staining (SP method) was used to detect the expression of MMP-9, MMP-2, TIMP-1, and TIMP-2 in two groups. The results were treated with semi-quantitative method and analyzed by using non-parameter rank sum test.

RESULTS

Immunohistochemical staining of tumor cells for MMP-9, TIMP-1, MMP-2, and TIMP-2 were noted 95.9% (47/49), 57.1% (28/49), 75.5% (37/49) and 89.8% (44/49) in invasive adenomas, and 100% (12/12), 91.7% (11/12), 66.7% (8/12), and 91.7% (11/12) in non-invasive adenomas, respectively. Invasive tumors were significantly less expressing TIMP-1 and TIMP-2 (P < 0.05). There was no significant difference for MMP-9 or MMP-2 between invasive and non-invasive groups (P > 0.05).

CONCLUSIONS

TIMP-1 and TIMP-2 may play a key role in invasive pituitary adenomas to biological behavior.

摘要

背景与目的

垂体腺瘤通常组织学上为良性且生长缓慢,但其中一部分会具有局部侵袭性,发展为侵袭性垂体腺瘤。肿瘤行为存在这些差异的原因尚不清楚。垂体腺瘤血管丰富。血管生成和肿瘤侵袭都需要细胞外基质成分降解以允许细胞迁移。基质金属蛋白酶(MMPs)及其天然抑制剂——金属蛋白酶组织抑制剂(TIMPs)可能在这些过程中起核心作用。通过研究MMP - 9、MMP - 2、TIMP - 1和TIMP - 2在侵袭性和非侵袭性腺瘤中的表达,探讨垂体腺瘤的侵袭机制。

方法

对61例手术切除的垂体腺瘤(49例侵袭性腺瘤和12例非侵袭性腺瘤)进行研究。采用免疫组织化学染色(SP法)检测两组中MMP - 9、MMP - 2、TIMP - 1和TIMP - 2的表达。结果采用半定量方法处理,并使用非参数秩和检验进行分析。

结果

侵袭性腺瘤中肿瘤细胞MMP - 9、TIMP - 1、MMP - 2和TIMP - 2的免疫组织化学染色阳性率分别为95.9%(47/49)、57.1%(28/49)、75.5%(37/49)和89.8%(44/49),非侵袭性腺瘤中分别为100%(12/12)、91.7%(11/12)、66.7%(8/12)和91.7%(11/12)。侵袭性肿瘤中TIMP - 1和TIMP - 2的表达明显较低(P < 0.05)。侵袭性和非侵袭性组之间MMP - 9或MMP - 2无显著差异(P > 0.05)。

结论

TIMP - 1和TIMP - 2可能在侵袭性垂体腺瘤的生物学行为中起关键作用。

相似文献

1
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].基质金属蛋白酶-9、2及其抑制剂-金属蛋白酶组织抑制因子-1、2在侵袭性垂体腺瘤生物学行为中的作用
Ai Zheng. 2002 Oct;21(10):1124-8.
2
[Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].[垂体腺瘤中基质金属蛋白酶及其组织抑制剂的表达与侵袭性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):647-50.
3
Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.基质金属蛋白酶及其抑制剂在髓母细胞瘤中的表达及其预后相关性。
Clin Cancer Res. 2004 Jul 15;10(14):4746-53. doi: 10.1158/1078-0432.CCR-0625-03.
4
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.基质金属蛋白酶及其组织抑制剂在子宫内膜癌中的表达以及基质金属蛋白酶-7表达与预后的相关性
Int J Mol Med. 2005 Oct;16(4):541-6.
5
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].[基质金属蛋白酶-9、2、7及金属蛋白酶组织抑制剂-1、2、3 mRNA在卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2004 Oct;23(10):1194-8.
6
[Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].[基质金属蛋白酶与金属蛋白酶组织抑制因子失衡在老年大鼠肾小管间质病变中的意义]
Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):937-42.
7
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].[基质金属蛋白酶-2、9及其抑制剂-基质金属蛋白酶组织抑制因子1、2在子宫颈鳞状细胞癌中的表达]
Ai Zheng. 2002 Jul;21(7):735-9.
8
Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.腹主动脉瘤壁中基质金属蛋白酶与金属蛋白酶组织抑制剂之间的关系。
Int Angiol. 2003 Sep;22(3):229-38.
9
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.丝氨酸蛋白酶和金属蛋白酶在人垂体腺瘤及垂体前叶组织中的表达
Acta Neuropathol. 2003 Nov;106(5):471-8. doi: 10.1007/s00401-003-0747-5. Epub 2003 Aug 2.
10
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.结直肠癌组织样本中基质金属蛋白酶2和7(MMP - 2、MMP - 7)以及基质金属蛋白酶组织抑制剂1和2(TIMP - 1、TIMP - 2)的定量测定
Anticancer Res. 2005 Sep-Oct;25(5):3387-91.

引用本文的文献

1
Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.基质金属蛋白酶-9和-2以及基质金属蛋白酶-2组织抑制剂在侵袭性垂体腺瘤中的研究:病例对照试验的系统评价和荟萃分析
Medicine (Baltimore). 2016 Jun;95(24):e3904. doi: 10.1097/MD.0000000000003904.